Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2010-10-19

AUTHORS

Scott E. McNeil

ABSTRACT

Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls. More... »

PAGES

3-8

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1

DOI

http://dx.doi.org/10.1007/978-1-60327-198-1_1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1034612500

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21116949


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Physical Chemistry (incl. Structural)", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Chemical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Delivery Systems", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug-Related Side Effects and Adverse Reactions", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanomedicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanoparticles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanostructures", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nanotechnology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surface Properties", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC \u2013 Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McNeil", 
        "givenName": "Scott E.", 
        "id": "sg:person.01066372523.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066372523.29"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/nrd1033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000722784", 
          "https://doi.org/10.1038/nrd1033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd1033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000722784", 
          "https://doi.org/10.1038/nrd1033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.93.24.14164", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001856115"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.addr.2005.09.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003846396"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-1634", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007182456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdl104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035014334"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1359-6446(03)02903-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038206642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10717540490433895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038778560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0168-3659(99)00248-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044151490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/0-306-47932-x_2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047588034", 
          "https://doi.org/10.1007/0-306-47932-x_2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.4.8.1213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067589512"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-10-19", 
    "datePublishedReg": "2010-10-19", 
    "description": "Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls.", 
    "editor": [
      {
        "familyName": "McNeil", 
        "givenName": "Scott E.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-1-60327-198-1_1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5246872", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": {
      "isbn": [
        "978-1-60327-197-4", 
        "978-1-60327-198-1"
      ], 
      "name": "Characterization of Nanoparticles Intended for Drug Delivery", 
      "type": "Book"
    }, 
    "name": "Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics", 
    "pagination": "3-8", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21116949"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1034612500"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-1-60327-198-1_1"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "a4e1bc1a2cf1f875c0fac7dc71f69fa4869461d93ba5144422ae1498ab376958"
        ]
      }
    ], 
    "publisher": {
      "location": "Totowa, NJ", 
      "name": "Humana Press", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-1-60327-198-1_1", 
      "https://app.dimensions.ai/details/publication/pub.1034612500"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T08:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000364_0000000364/records_72859_00000000.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-1-60327-198-1_1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-1-60327-198-1_1'


 

This table displays all metadata directly associated to this object as RDF triples.

142 TRIPLES      23 PREDICATES      47 URIs      30 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-1-60327-198-1_1 schema:about N0b50f21594a44376baa5a7c87d0ca9e7
2 N1883b8c9b52f495c87a847f7f7e0dc98
3 N2273f5f392174aba879ffd3a14a4b3dc
4 N5eda1697c3ee4a1dab87504601f0a82f
5 Na346f6d8832f4b57af3f37e48a8d3254
6 Nad2113beb15c4772a9c509c0982394aa
7 Nc084f3ebb7ed4978ab2a4f868e3b03f1
8 Nd3e02c37aff04e06867a04eba7ff2360
9 Ne5709e8e67f34d95a0be8bcfb40bdda1
10 Nfd309ccf0abf44b3b4fddd858ba78b88
11 anzsrc-for:03
12 anzsrc-for:0306
13 schema:author N6c9943fecee14ef7ac2453ec2fa7832f
14 schema:citation sg:pub.10.1007/0-306-47932-x_2
15 sg:pub.10.1038/nrd1033
16 https://doi.org/10.1016/j.addr.2005.09.014
17 https://doi.org/10.1016/s0168-3659(99)00248-5
18 https://doi.org/10.1016/s1359-6446(03)02903-9
19 https://doi.org/10.1073/pnas.93.24.14164
20 https://doi.org/10.1080/10717540490433895
21 https://doi.org/10.1093/annonc/mdl104
22 https://doi.org/10.1158/1078-0432.ccr-05-1634
23 https://doi.org/10.1517/14712598.4.8.1213
24 schema:datePublished 2010-10-19
25 schema:datePublishedReg 2010-10-19
26 schema:description Nanotechnology offers many potential benefits to medical research by making pharmaceuticals more efficacious and by decreasing their adverse side-effects. Preclinical characterization of nanoparticles intended for medical applications is complicated--due to the variety of materials used, their unique surface properties and multifunctional nature. This chapter serves as an introduction to the volume, giving a broad overview of applications of nanotechnology to medicine, and describes some of the beneficial aspects of nanotechnology-based drug delivery. We define nanotechnology and provide brief descriptions of the major classes of nanomaterials used for medical applications. The following two chapters discuss scientific and regulatory hurdles involved in the use of nanotechnology in medicine. The remaining bulk of the volume provides the reader with protocols that have been tested against clinically relevant nanoparticles and describes some of the nuances of nanoparticle types and necessary controls.
27 schema:editor N9e2c85ecbeda4e539cee35623563c9f0
28 schema:genre chapter
29 schema:inLanguage en
30 schema:isAccessibleForFree false
31 schema:isPartOf N208ce22a795248539e9e8b64e4f0f88b
32 schema:name Unique Benefits of Nanotechnology to Drug Delivery and Diagnostics
33 schema:pagination 3-8
34 schema:productId N1925536c45584aa786c79e10dbe8d59c
35 N3e5d7e57ae31403c8bb92dbef00382c6
36 N949219e1ca124ece9040ce47a94d3c81
37 Nb3c65dfca8394cb09d54b5cfa596c3e8
38 schema:publisher Nf101dd1a35434bcebb554042e3897926
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034612500
40 https://doi.org/10.1007/978-1-60327-198-1_1
41 schema:sdDatePublished 2019-04-16T08:32
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N10c8143a439f4d55a04c0ff03d96e13d
44 schema:url https://link.springer.com/10.1007%2F978-1-60327-198-1_1
45 sgo:license sg:explorer/license/
46 sgo:sdDataset chapters
47 rdf:type schema:Chapter
48 N0b50f21594a44376baa5a7c87d0ca9e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Surface Properties
50 rdf:type schema:DefinedTerm
51 N100ad8f786ec449aa4066dba8158a1de schema:familyName McNeil
52 schema:givenName Scott E.
53 rdf:type schema:Person
54 N10c8143a439f4d55a04c0ff03d96e13d schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 N1883b8c9b52f495c87a847f7f7e0dc98 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
57 schema:name Nanomedicine
58 rdf:type schema:DefinedTerm
59 N1925536c45584aa786c79e10dbe8d59c schema:name doi
60 schema:value 10.1007/978-1-60327-198-1_1
61 rdf:type schema:PropertyValue
62 N208ce22a795248539e9e8b64e4f0f88b schema:isbn 978-1-60327-197-4
63 978-1-60327-198-1
64 schema:name Characterization of Nanoparticles Intended for Drug Delivery
65 rdf:type schema:Book
66 N2273f5f392174aba879ffd3a14a4b3dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Animals
68 rdf:type schema:DefinedTerm
69 N3e5d7e57ae31403c8bb92dbef00382c6 schema:name dimensions_id
70 schema:value pub.1034612500
71 rdf:type schema:PropertyValue
72 N55162ef69cb14a43a5f40f60b1198051 schema:name Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC – Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD, USA
73 rdf:type schema:Organization
74 N5eda1697c3ee4a1dab87504601f0a82f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N6c9943fecee14ef7ac2453ec2fa7832f rdf:first sg:person.01066372523.29
78 rdf:rest rdf:nil
79 N949219e1ca124ece9040ce47a94d3c81 schema:name readcube_id
80 schema:value a4e1bc1a2cf1f875c0fac7dc71f69fa4869461d93ba5144422ae1498ab376958
81 rdf:type schema:PropertyValue
82 N9e2c85ecbeda4e539cee35623563c9f0 rdf:first N100ad8f786ec449aa4066dba8158a1de
83 rdf:rest rdf:nil
84 Na346f6d8832f4b57af3f37e48a8d3254 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Drug-Related Side Effects and Adverse Reactions
86 rdf:type schema:DefinedTerm
87 Nad2113beb15c4772a9c509c0982394aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Nanotechnology
89 rdf:type schema:DefinedTerm
90 Nb3c65dfca8394cb09d54b5cfa596c3e8 schema:name pubmed_id
91 schema:value 21116949
92 rdf:type schema:PropertyValue
93 Nc084f3ebb7ed4978ab2a4f868e3b03f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Drug Delivery Systems
95 rdf:type schema:DefinedTerm
96 Nd3e02c37aff04e06867a04eba7ff2360 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Nanoparticles
98 rdf:type schema:DefinedTerm
99 Ne5709e8e67f34d95a0be8bcfb40bdda1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Nanostructures
101 rdf:type schema:DefinedTerm
102 Nf101dd1a35434bcebb554042e3897926 schema:location Totowa, NJ
103 schema:name Humana Press
104 rdf:type schema:Organisation
105 Nfd309ccf0abf44b3b4fddd858ba78b88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Pharmaceutical Preparations
107 rdf:type schema:DefinedTerm
108 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
109 schema:name Chemical Sciences
110 rdf:type schema:DefinedTerm
111 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
112 schema:name Physical Chemistry (incl. Structural)
113 rdf:type schema:DefinedTerm
114 sg:grant.5246872 http://pending.schema.org/fundedItem sg:pub.10.1007/978-1-60327-198-1_1
115 rdf:type schema:MonetaryGrant
116 sg:person.01066372523.29 schema:affiliation N55162ef69cb14a43a5f40f60b1198051
117 schema:familyName McNeil
118 schema:givenName Scott E.
119 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066372523.29
120 rdf:type schema:Person
121 sg:pub.10.1007/0-306-47932-x_2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047588034
122 https://doi.org/10.1007/0-306-47932-x_2
123 rdf:type schema:CreativeWork
124 sg:pub.10.1038/nrd1033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000722784
125 https://doi.org/10.1038/nrd1033
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/j.addr.2005.09.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003846396
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0168-3659(99)00248-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044151490
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1016/s1359-6446(03)02903-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038206642
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1073/pnas.93.24.14164 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001856115
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1080/10717540490433895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038778560
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1093/annonc/mdl104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035014334
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1158/1078-0432.ccr-05-1634 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007182456
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1517/14712598.4.8.1213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589512
142 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...